CURRENT STEM CELL RESEARCH & THERAPY, vol.13, no.6, pp.447-457, 2018 (SCI-Expanded)
Article / Review
CURRENT STEM CELL RESEARCH & THERAPY
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Conductivity, coronary artery disease, graphene, stem cells, therapy, tissue engineering, SKELETAL MYOBLAST TRANSPLANTATION, ENDOTHELIAL PROGENITOR CELLS, RANDOMIZED PHASE-1 TRIAL, BONE-MARROW, MYOCARDIAL-INFARCTION, GROWTH-FACTORS, CARDIOMYOGENIC DIFFERENTIATION, ELECTROCHEMICAL REDUCTION, ANTIBACTERIAL ACTIVITY, INTERNATIONAL-SOCIETY
Yıldız Technical University Affiliated:
Background: Today, coronary artery disease is still one of the most important causes of mortality despite advanced surgical methods, pharmacotherapies and organ transplantation. These treatment modalities are intended to prevent further progression of myocardial infarction and do not involve the repair of the damaged part. Therefore, stem cell therapy has emerged as a new approach for the treatment of coronary artery disease. However, there are some restrictions that limit the use of these cells for desired repair. The leading limitation is that newly formed cardiomyocytes do not provide electrical integrity with local cells.